Does elevated C-reactive protein increase atrial fibrillation risk? A mendelian randomization of 47,000 individuals from the general population

Journal of the American College of Cardiology

Volumn 56, Issue 10, 2010, Pages 789-795

  Marott, Sarah C W ^a,b   Nordestgaard, Børge G ^a,b,c   Zacho, Jeppe ^a,b   Friberg, Jens ^b,d   Jensen, Gorm B ^b,c,d   Tybjærg Hansen, Anne ^a,b,c,e   Benn, Marianne ^a,b,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

atrial fibrillation; C reactive protein; genetics; inflammation; Mendelian randomization

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GENOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 77956158589     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.02.066     Document Type: Article

References (14)

1. P.T. Ellinor, A. Low, K.K. Patton, M.A. Shea, and C.A. MacRae C-reactive protein in lone atrial fibrillation Am J Cardiol 97 2006 1346 1350
2. B. Pirat, I. Atar, and C. Ertan Comparison of C-reactive protein levels in patients who do and do not develop atrial fibrillation during electrophysiologic study Am J Cardiol 100 2007 1552 1555
3. O.D. Pedersen, H. Bagger, L. Kober, and C. Torp-Pedersen Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction Circulation 100 1999 376 380
4. K. Wachtell, M. Lehto, and E. Gerdts Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study J Am Coll Cardiol 45 2005 712 719
5. G.D. Lowe, and M.B. Pepys C-reactive protein and cardiovascular disease: weighing the evidence Curr Atheroscler Rep 8 2006 421 428
6. G.D. Smith, and S. Ebrahim Mendelian randomization: prospects, potentials, and limitations Int J Epidemiol 33 2004 30 42
7. C.S. Carlson, S.F. Aldred, and P.K. Lee Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels Am J Hum Genet 77 2005 64 77
8. J. Zacho, A. Tybjaerg-Hansen, J.S. Jensen, P. Grande, H. Sillesen, and B.G. Nordestgaard Genetically elevated C-reactive protein and ischemic vascular disease N Engl J Med 359 2008 1897 1908
9. B.G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjaerg-Hansen Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 2007 299 308
10. R.J. Aviles, D.O. Martin, and C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
11. M.K. Chung, D.O. Martin, and D. Sprecher C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
12. J.L. Anderson, C.A. Allen Maycock, and D.L. Lappe Frequency of elevation of C-reactive protein in atrial fibrillation Am J Cardiol 94 2004 1255 1259
13. K.J. Mukamal, J.S. Tolstrup, J. Friberg, M. Gronbaek, and G. Jensen Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study) Am J Cardiol 98 2006 75 81
14. D.A. Lawlor, R.M. Harbord, J.A. Sterne, N. Timpson, and S.G. Davey Mendelian randomization: using genes as instruments for making causal inferences in epidemiology Stat Med 27 2008 1133 1163